Singular Genomics Sys: Q4 Earnings Insights
$OMIC
Biotechnology: Laboratory Analytical Instruments
Industrials
Singular Genomics Sys (NASDAQ:OMIC) reported its Q4 earnings results on Monday, March 18, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Singular Genomics Sys beat estimated earnings by 6.0%, reporting an EPS of $-0.32 versus an estimate of $-0.34.
Revenue was up $316 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 7.000000000000001% increase in the share price the next day.
Here's a look at Singular Genomics Sys's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -0.37 | -0.35 | -0.43 |
| EPS Actual | -0.31 | -0.35 | -0.33 | -0.29 |
| Revenue Estimate | 1.27M | 1.15M | 1.24M | 760K |
| Revenue Actual | 462K | 505K | 863K | 765K |
To track all earnings releases for Singular Genomics Sys visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.